Informationen:
Fehler:
ID
25534
Beschreibung
Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00474838
Link
https://clinicaltrials.gov/show/NCT00474838
Stichworte
Versionen (1)
- 05.09.17 05.09.17 -
Hochgeladen am
5. September 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Type 2 Diabetes Mellitus NCT00474838
Eligibility Type 2 Diabetes Mellitus NCT00474838
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Type 2 Diabetes Mellitus NCT00474838
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Therapy naive Non-Insulin-Dependent Diabetes Mellitus | Symptoms Diabetic | Polydipsia | Polyuria | Unexplained weight loss
Item
newly diagnosed drug naïve type 2 diabetic patient with typical diabetic symptom (polydipsia, polyuria, unexplained weight loss) within recent 1 year
boolean
C0919936 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
C1457887 (UMLS CUI [2,1])
C0241863 (UMLS CUI [2,2])
C0085602 (UMLS CUI [3])
C0032617 (UMLS CUI [4])
C1828173 (UMLS CUI [5])
C0011860 (UMLS CUI [1,2])
C1457887 (UMLS CUI [2,1])
C0241863 (UMLS CUI [2,2])
C0085602 (UMLS CUI [3])
C0032617 (UMLS CUI [4])
C1828173 (UMLS CUI [5])
Glycosylated hemoglobin A
Item
initial hba1c : 8.0 % ≤ hba1c < 12.0%
boolean
C0019018 (UMLS CUI [1])
Medical contraindication Insulin Glargine | Medical contraindication Insulin Glulisine | Medical contraindication Metformin | Medical contraindication glimepiride
Item
known contraindication to insulin glargine, insulin glulisine, metformin, glimepiride
boolean
C1301624 (UMLS CUI [1,1])
C0907402 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C1313386 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0025598 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0061323 (UMLS CUI [4,2])
C0907402 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C1313386 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0025598 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0061323 (UMLS CUI [4,2])
Proliferative diabetic retinopathy
Item
patients with proliferative diabetic retinopathy
boolean
C0154830 (UMLS CUI [1])
Liver disease Severe | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
severe liver disease or ast, alt ≥ 2.5 x uln
boolean
C0023895 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
C0205082 (UMLS CUI [1,2])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
Acidosis, Lactic
Item
history of lactic acidosis
boolean
C0001125 (UMLS CUI [1])
Angina, Unstable | Angina Pectoris Severe
Item
unstable or severe angina
boolean
C0002965 (UMLS CUI [1])
C0002962 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0002962 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Congestive heart failure
Item
congestive heart failure
boolean
C0018802 (UMLS CUI [1])
Steroid therapy Chronic disease
Item
chronic disease treated with continuous corticosteroid therapy
boolean
C0149783 (UMLS CUI [1,1])
C0008679 (UMLS CUI [1,2])
C0008679 (UMLS CUI [1,2])
Malignant Neoplasms
Item
diagnosis of cancer
boolean
C0006826 (UMLS CUI [1])
Urine pregnancy test positive | Pregnancy, Planned
Item
positive urine pregnancy test or plan to become pregnant during the clinical trial
boolean
C0430059 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0032992 (UMLS CUI [2])